
Loading, please wait...

Loading, please wait...

Colorectal cancer remains a leading cause of mortality worldwide, necessitating advanced techniques for real-time tumor detection. While neoadjuvant chemoradiation therapy (nCRT) followed by total mesorectal excision is the standard treatment for locally advanced rectal cancer, surgeons often face challenges with incomplete resections. Poor intraoperative tumor visualization frequently leads to suboptimal outcomes. Consequently, researchers have developed PH10, a topical pH-activatable near-infrared (NIR) fluorescent probe, to bridge this diagnostic gap.
PH10 functions as a small-molecule cyanine analog that specifically targets the acidic tumor microenvironment. Unlike traditional "always-on" dyes, this probe activates only when it encounters low pH levels typical of malignant tissues. In murine models, researchers observed a median tumor-to-background ratio (TBR) of 3.2 within just one minute. Furthermore, ex vivo human samples demonstrated a TBR of 2.2 within ten minutes. This rapid kinetics profile allows clinicians to visualize margins effectively during endoscopy and surgery.
Notably, the topical application of PH10 offers significant advantages over systemic administration. It avoids potential systemic toxicities and eliminates the need for prolonged incubation periods. Therefore, surgeons can apply the fluorophore directly to the area of interest for immediate feedback. Moreover, the pH-activatable mechanism might extend its utility to other solid tumors characterized by acidic microenvironments. This innovation could refine the "watch-and-wait" strategy for patients with complete nCRT responses, as better imaging identifies those at risk of regrowth more accurately.
The integration of PH10 into clinical practice represents a significant shift toward precision oncology. By providing high specificity without requiring complex equipment, this agent supports rapid clinical translation. Surgeons can potentially minimize morbidity by ensuring complete resections while sparing healthy tissue. Additionally, the probe's compatibility with standard NIR imaging systems makes it a practical addition to modern operating rooms.
PH10 utilizes a pH-activatable mechanism. It remains non-fluorescent in neutral environments but activates its near-infrared signal upon encountering the acidic microenvironment inherent to solid tumors.
Topical application allows for rapid kinetics, with visualization occurring in under ten minutes. It also reduces systemic exposure and side effects, providing a safer and faster alternative for real-time surgical guidance.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult with a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Linders DGJ et al. Real-Time Detection of Colorectal Cancer Using Topical Application of a pH-Activatable Fluorophore. Mol Diagn Ther. 2026 May 23. doi: 10.1007/s40291-026-00853-6. PMID: 42174369.
Romanò G, et al. Role of near-infrared fluorescence in colorectal surgery. World J Gastrointest Surg. 2024;16(2):123-135.
Low PS, et al. Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol. 2018;15(7):402-415.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


PH10 is a novel pH-activatable NIR fluorophore that allows rapid, specific real-time tumor detection in colorectal cancer, enhancing surgical precision....
5 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A 25-year multi-institutional cohort reveals high recurrence rates in pediatric giant cell tumor of bone, particularly in patients with open physes and bone marrow edema on preoperative MRI. Early surveillance and careful balance between growth plate preservation and tumor clearance are essential.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today